Compare MYGN & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | LWAY |
|---|---|---|
| Founded | 1991 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 368.4M |
| IPO Year | 1996 | 1995 |
| Metric | MYGN | LWAY |
|---|---|---|
| Price | $6.29 | $31.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $7.64 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 1.5M | 199.6K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.33 |
| EPS | N/A | ★ 0.30 |
| Revenue | ★ $771,400,000.00 | $103,350,000.00 |
| Revenue This Year | $6.86 | $16.64 |
| Revenue Next Year | $5.45 | $17.28 |
| P/E Ratio | ★ N/A | $108.07 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.53 | $17.31 |
| 52 Week High | $8.59 | $34.20 |
| Indicator | MYGN | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 70.35 | 65.48 |
| Support Level | $6.09 | $22.27 |
| Resistance Level | $7.29 | N/A |
| Average True Range (ATR) | 0.34 | 1.62 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 93.91 | 73.61 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.